2021 American Transplant Congress » Liver: Hepatocellular Carcinoma and Other Malignancies

Date & Time:
None. Available on demand

Location: Virtual

Session Type: Poster Abstract

Meeting: 2021 American Transplant Congress

Albumin Level Prior to Liver-Directed Therapy is a Risk Factor of Waitlist Tumor Progression Independent of HCC Burden

P. Thevenot, K. Nunez, T. Sandow, M. Hibino, P. Wright, J. Patel, D. Fort, A. Cohen
Effects of TIPS on Transplant Outcomes for HCC

C. L. Hanlon¹, D. Toy¹, Y. Liu¹, S. Zhou¹, K. Zhou², J. Kahn², L. Yuan²
Excellent Pathological Response with Gemcitabine-based Protocol in Patient with Hilar Cholangiocarcinoma

A. Saharia¹, R. McMillan¹, S. Kodali¹, M. Javley², C. M. Mobley¹, M. J. Hobeika¹, A. Shetty¹, D. W. Victor¹, R. McFadden¹, M. Abdelrahim¹, K. Heyne¹, A. O. Gaber¹, R. M. Ghobrial¹
Given the Potential Impact on Liver Transplant Selection, Revisiting the Current Standard of Diagnosis of Hepatocellular Carcinoma

K. Amarell, B. Fisher, B. Park, K. Ko, B. Kallakury
Immunotherapy of Dc-cik Cells in Patient with Hepatocellular Carcinoma Recurrence Following Liver Transplantation

S. Hsu, L. Jeng, H. Yang, A. Thorat
Impact of Donation After Circulatory Death Donor Allografts on Outcomes Following Liver Transplantation for Cholangiocarcinoma

S. Kumar¹, S. Lin², J. D. Schold²
Improving Liver Transplantation Outcomes for Hepatitis C Associated Hepatocellular Carcinoma in Direct-Acting Antiviral Therapy Era

K. Okumura, H. Sogawa, G. Veillette, D. John, T. Diflo, R. Bodin, D. C. Wolf, S. Nishida
Intrahepatic Spatial Location of HCC Recurrence Following Loco-regional Therapy for Solitary Tumors Predicts a Higher Oncologic Risk & Increased Recurrence Post-transplant

A. Mathur, E. Baughan, S. Haider, A. Griesemer, T. Kato, J. Emond
Liver Transplantation Following Checkpoint Inhibitor Therapy – Timing is Everything

G. T. Schnickel¹, J. Parekh¹, Y. Kono², J. Berumen¹, V. Ajmeera², K. Mekeel¹
Outcomes of Surgical Resection versus Liver Transplantation in Hilar Cholangiocarcinoma

M. K. White¹, F. Aucejo², A. Moro², K. Sasaki², K. Stephans³, B. Estfan⁴, C. Quintini², B. Eghtesad², K. Hashimoto², F. Masato², C. Miller², K. Menon⁵
Pilot Evaluation of Prognosis After Liver Transplantation in Patients with a History of Hepatocellular Carcinoma and Pd-1 Inhibition

M. Chen¹, Z. Chen¹, X. Lin²
Review of 10-Year Liver Explant Pathology Impact on Outcomes in a Single Center

Y. K. Kwon¹, L. Sher¹, S. Khemichian², J. Kahn², Y. Genyk¹
The Role of Histone Acetylation/methylation Mediated Epigenetic Modifications in the Pathogenesis of Non-alcoholic Steatohepatitis-associated Liver Carcinogenesis

P. K. Rajan¹, U. Utibe-Abasi¹, J. D. Sanabria¹, M. Banerjee², G. Smith¹, M. S. Schade¹, J. Sanabria¹, K. Sodhi¹, S. Pierre², Z. Xie², J. I. Shapiro², J. Sanabria¹

« View all sessions from the 2021 American Transplant Congress